GLOBVAC-Global helse- og vaksin.forskn

Meningococcal vaccines for Africa: Impact of MenAfriVac on serogroup A transmission and clinical evaluation of a new protein-based vaccine

Meningokokkbakterien Neisseria meningitidis er en viktig årsak til bakterielt meningitt (smittsom hjernehinnebetennelse) i landene sør for Sahara. I meningittbeltet, et område fra Senegal til Etiopia med verdens fattigste land, blir titusener av mennesker smittet årlig og tusener av mennesker dør...

Tildelt: kr 16,4 mill.

Prosjektperiode: 2013-2018

Sted: Oslo

GLOBHELS-Global helse

Additional activities related to an ongoing project: Impact of the new vaccine MenAfriVac on carriage of serogroup A Neisseria meningitidis

Meningitis due to Neisseria meningitidis serogroup A represents an important public health problem in sub-Saharan Africa. New meningitis vaccines (against pneumococci, Hemophilus influenzae and serogroup C meningococci) manufactured by conjugating the pol ysaccharide to a carrier protein have bee...

Tildelt: kr 2,9 mill.

Prosjektperiode: 2010-2012

Sted: Oslo

GLOBHELS-Global helse

Impact of a new and affordable conjugate meningococcal vaccine on carriage of serogroup A Neisseria meningitidis and disease transmission

Meningococcal meningitis is causing repeated massive epidemics in an area south of Sahara, termed the meningitis belt. The disease-causing bacteria are mainly serogroup A meningococci. These are transmitted between individuals by air-borne droplets and as ymptomatic carriers are the principal sou...

Tildelt: kr 11,1 mill.

Prosjektperiode: 2008-2011

Sted: Oslo

BIOMOL-Molekylær biovitenskap og bioteknologi

Severe Streptococcus pyogenes infections in Norway - Molecular genetic analysis of antibiotic resistance and virulence determinants

Group A streptococci is one of the most common human pathogens that can produce a variety of diseases ranging from mild pharyngitis (strep throat) to life-threatening toxic shock syndrome and necrotizing fasciitis. The incidence of invasive streptococcal disease has been increasing in Norway in t...

Tildelt: kr 0,16 mill.

Prosjektperiode: 2007-2007

Sted: Oslo

MILGENHEL-Miljø, gener og helse

Severe Streptococcus pyogenes infections in Norway - Molecular genetic analysis of antibiotic resistance and virulence determinants

Group A streptococci is one of the most common human pathogens that can produce a variety of diseases ranging from mild pharyngitis ("strep throat") to life-threatening toxic shock syndrome and necrotizing fasciitis. The incidence of invasive streptococca l disease has been increasing in Norway i...

Tildelt: kr 1,8 mill.

Prosjektperiode: 2005-2009

Sted: Oslo

AB-MED1-Basal medisinsk forskning I

Antibiotic resistance and molecular epidemiology of Streptococcus pneumoniae in Norway

...

Tildelt: kr 1,5 mill.

Prosjektperiode: 2001-2007

Sted: Oslo